Premium
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement
Author(s) -
Bhabha Friyana K,
McCormack Christopher,
Wells Jillian,
Campbell Belinda A,
Newland Kate,
Lade Stephen,
Buelens Odette,
Joske David,
Shortt Jake,
Mapp Sally,
Radeski Dejan,
Hertzberg Mark,
Khot Amit,
Van Der Weyden Carrie,
Khoo Christine,
Hawkes Eliza,
Prince H Miles
Publication year - 2021
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.13467
Subject(s) - mycosis fungoides , medicine , statement (logic) , clinical practice , dermatology , lymphoma , pathology , family medicine , political science , law
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).